NCT02541383: Phase 3 - Bortezomib, thalidomide, dex +/-Daratumumab before & after ASCT (CASSIOPEIA)
The CASSIOPEIA trial IFM / HOVON IFM 2015-01 HOVON HO131 MM Newly Diagnosed Multiple Myeloma A Study to Evaluate Daratumumab in...
Dec 31, 2015
NCT02336815 : Phase 2 - Selinexor Treatment of Refractory Myeloma (STORM)
STORM Selinexor Treatment of Refractory Myeloma (STORM) This is a Phase 2b, single-arm, open-label, multicenter study of selinexor 80 mg...
Dec 30, 2015
NCT02332850: Phase Ib Study of SAR650984 With Carfilzomib for Treatment of Relapsed Multiple Myeloma
Multiple Myeloma Research Consortium NCT02332850: Phase Ib Study of SAR650984 With Carfilzomib for Treatment of Relapsed Multiple Myeloma...
Dec 23, 2015
Cancer Therapy: Oral Medication Basics: Information for Patients and Families (Targeted Therapy)
Cleveland Clinic Cancer Therapy: Oral Medication Basics: Information for Patients and Families (Targeted Therapy)
Dec 20, 2015
Cancer Therapy: Oral Medication Basics: Information for Patients and Families (Chemotherapy)
Cleveland Clinic: Cancer Therapy: Oral Medication Basics: Information for Patients and Families (Chemotherapy)
Dec 20, 2015
Myeloma UK - Myeloma Animations Series: Proteasome inhibitors in myeloma
Myeloma UK - Myeloma Animations Proteasome inhibitors in myeloma Learn More: https://www.myeloma.org.uk/
Dec 19, 2015